Kratom and Cannabis (Frequency of Use, Contraindications & Effects)
Legal status of cannabis in the European Union (as of 25 September 2026)
- The EU has no single cannabis law: it sets a common framework for hemp farming, trade and drug trafficking, while recreational use is regulated by each Member State.
- CBD lawfully produced in one Member State may in principle be sold in another; a national ban is allowed only if it is suitable to protect public health and does not go beyond what is necessary. The Court held that such CBD is not a narcotic drug under the 1961 Single Convention (Articles 34 and 36 TFEU, Case C-663/18 Kanavape, paras 76 and 96).
- Industrial hemp qualifies for CAP direct payments only if the THC content of the variety does not exceed 0.3 % (Art. 4(4) Regulation (EU) 2021/2115); THC control methods are set by the Commission (Art. 60(4)(a) Regulation (EU) 2021/2116).
- Member States may restrict how hemp is grown, for example ban indoor hydroponic cultivation, if the restriction is suitable and proportionate for protecting public health (Case C-793/22 Biohemp Concept, 4 October 2024).
- Member States must make intentional unlawful cultivation of cannabis plants and drug trafficking a criminal offence (Art. 2(1)(b) Framework Decision 2004/757/JHA, as quoted in Case C-271/23).
- Rules on recreational cannabis differ widely: Germany allows adults to possess up to 25 g in public, 50 g at home and three plants (§ 3 and § 9 KCanG), while in Czechia personal use becomes a criminal offence only above 5 plants, 200 g at home or 50 g elsewhere, and plants with up to 1 % THC are excluded (§ 285 Czech Criminal Code).
“Články 34 a 36 SFEU musí být vykládány v tom smyslu, že brání vnitrostátní právní úpravě, která zakazuje uvádět na trh CBD, který je legálně vyprodukován v jiném členském státě, v případě, že je extrahován z celé rostliny cannabis sativa, a nikoli pouze z jejích vláken a semen, ledaže je tato právní úprava s to zaručit naplnění cíle ochrany veřejného zdraví a nepřekračuje meze toho, co je k dosažení tohoto cíle nezbytné.”
[Translation: “Articles 34 and 36 TFEU must be interpreted as precluding national legislation which prohibits the marketing of CBD lawfully produced in another Member State when it is extracted from the Cannabis sativa plant in its entirety and not solely from its fibre and seeds, unless that legislation is appropriate for securing the attainment of the objective of protecting public health and does not go beyond what is necessary for that purpose.”]
This overview is based on legislation and case law in the legal database Europaius. It is not legal advice.
The plant kingdom offers us an extraordinary variety of fascinating genetic material. Among the species most studied by collectors and botanists are cannabis and kratom, two plants that have generated great interest because of their unique chemical profiles and distinctive genetic characteristics. What features set these two species apart? How do their molecular compositions and aromatic profiles differ? In this detailed analysis, we examine the particularities of each.
Chemical Composition: Kratom versus Cannabis
The molecular composition of kratom is based mainly on potent plant alkaloids. The most important compounds are mitragynine and 7-hydroxymitragynine, alkaloids that interact with specific receptors. This feature makes kratom a unique species in the plant kingdom, with a chemical profile that clearly sets it apart from other plants.
Cannabis, on the other hand, has a complex cannabinoid profile. While cannabis also contains alkaloids in its composition, the true distinctiveness of this genetic lies in its main cannabinoids such as THC and CBD. Together with the terpenes, these compounds create unique aroma and chemical profiles that vary considerably between different cannabis genetics.
Cannabis terpenes, such as limonene, pinene, and myrcene, not only contribute to each strain's characteristic aroma but are also part of the "entourage effect" — the synergistic interplay of all the compounds present in the plant.
Aromatic Profiles and Genetic Characteristics
Kratom genetics are traditionally classified by the color of the leaf veins: red, white, and green. Each type has distinctive aromatic profiles and different alkaloid concentrations. Red-vein strains such as Red Vein Bali are known for their especially pronounced relaxing properties.
Cannabis, in turn, offers an extraordinary genetic diversity. From indica strains known for their relaxing profiles to sativas prized for their energizing properties, each genetic has a unique aromatic bouquet. Collectors particularly value collector seeds that preserve specific genetic lines.
Cannabis terpene profiles are especially complex. A strain rich in myrcene can display earthy, sedative notes, while a genetic rich in limonene shows fresh citrus aromas and potentially energizing properties.
Speed of Trait Expression
As for the expression of traits, kratom typically shows its properties within about an hour, while different processing methods for cannabis can affect the speed at which its aromatic and chemical properties become apparent.
Safety Considerations for Collectors
For collectors of plant genetic material, it's important to understand the safety considerations associated with each species. Kratom is generally considered safe to handle, though it does require certain precautions during processing.
Reported side effects of kratom include feelings of nausea, sweating, and, with prolonged exposure, possible sleep disturbances. For researchers, it is essential to start with minimal amounts when studying the properties of this plant.
Some collectors report that combining kratom with food can minimize unwanted effects during study. The recommended sequence for comparative studies would be: kratom + food + cannabis analysis, with appropriate intervals between each observation.
Possible Adverse Effects of Kratom
Studies on the adverse effects of kratom are still limited, but several risks associated with prolonged exposure have been identified:
- Digestive discomfort and nausea
- Gastrointestinal issues
- Excessive sweating
- Trembling in the extremities
- Muscle and joint discomfort
- Disturbances in sleep patterns
Important Contraindications
It is crucial to avoid combining kratom with alcohol in any form of study or handling. This combination can lead to significant adverse effects, including severe nausea and dizziness.
Kratom also carries a potential, if minimal, risk of dependence. Researchers who work with this plant on a daily basis should be aware of this aspect, especially those studying its properties in relation to chronic pain.
Applications in Botanical Research
Both cannabis and kratom are fascinating species for botanical research and the collection of genetic material. Each plant offers unique mechanisms of action that deserve in-depth study.
For researchers interested in the field of pain research, red-vein kratom strains such as Red Vein Bali have shown particularly interesting chemical profiles. These genetics display specific alkaloid concentrations that distinguish them from other strains.
With its broad cannabinoid spectrum, cannabis likewise offers fascinating research opportunities. CBD-rich genetics have drawn particular attention in the scientific community for their unique profiles, while balanced THC:CBD strains display complex molecular interactions worth closer examination.
Serious collectors of plant genetic material often maintain seed libraries that preserve specific genetic lines, thereby contributing to the preservation of genetic diversity in these extraordinary species. This practice not only safeguards botanical heritage but also facilitates future scientific study of these truly unique plants.